Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Eaton Vance Ohio Municipal Income Trust
(NQ:
EVO
)
3.530
+0.010 (+0.28%)
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 6, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Eaton Vance Ohio Municipal Income Trust
< Previous
1
2
3
4
5
Next >
Just - Evotec Biologics Expands Development and Manufacturing Agreement with ABL for Broadly Neutralising Antibodies Against HIV
February 06, 2024
Via
ACCESSWIRE
Evotec SE: Invitation to Conference Call
January 21, 2024
Via
ACCESSWIRE
Evotec and Crohn's & Colitis Foundation Enter Agreement to Advance Drug Discovery for Novel IBD Therapies
January 10, 2024
Via
ACCESSWIRE
Evotec Announces Progress in Strategic Neuroscience Partnership with Bristol Myers Squibb
January 07, 2024
Via
ACCESSWIRE
Evotec and Owkin Enter an A.I.-Powered Strategic Partnership to Accelerate Therapeutics Pipeline in Oncology and I&I
January 03, 2024
Via
ACCESSWIRE
Evotec SE Provides Update on Cyber Attack
April 10, 2023
Via
ACCESSWIRE
Evotec Announces CEO Transition
January 03, 2024
Via
ACCESSWIRE
Evotec receives US$ 2.5 M Grant to Leverage Human iPSC-Derived Teratogenicity Platform for Global Health Programmes
December 18, 2023
Via
ACCESSWIRE
Evotec Enters Partnership with Charité to Expand Molecular Patient Database in Autoimmune Diseases
December 14, 2023
Via
ACCESSWIRE
Evotec-partner Jingxin Receives Approval for EVT201 in China
December 06, 2023
Via
ACCESSWIRE
Evotec Presents Precision Medicine Platforms for Accelerated Pipeline Building at Capital Markets Day
November 15, 2023
Via
ACCESSWIRE
Evotec SE Reports Results for the First Nine Months 2023 and Provides Corporate Update
November 08, 2023
Via
ACCESSWIRE
Evotec and Dewpoint Therapeutics Enter Strategic Partnership in Oncology
November 07, 2023
Via
ACCESSWIRE
Evotec, ClavystBio, Leaps by Bayer, Lightstone Ventures and Polaris Partners launch '65LAB'
October 05, 2023
Via
ACCESSWIRE
Evotec SE: Launch of Partnering Agreement to Strengthen Biotech Innovators in Shared R&D Economy
September 27, 2023
Via
ACCESSWIRE
Evotec and Novo Nordisk Launch LAB eN² to Accelerate Translation in Cardiometabolic Diseases
September 26, 2023
Via
ACCESSWIRE
Evotec SE Reports Results for the First Half-year 2023 and Provides Corporate Updates
August 29, 2023
Via
ACCESSWIRE
Evotec SE Reports First Half-Year 2023 Results on 29 August 2023
August 22, 2023
Via
ACCESSWIRE
Evotec Provides Update on Financial Impact of Cyber-Attack
July 27, 2023
Via
ACCESSWIRE
Evotec and Bristol Myers Squibb Enter Licence Agreement within Neuroscience Partnership
July 11, 2023
Via
ACCESSWIRE
Just - Evotec Biologics Awarded Second Contract from U.S. Department of Defense Under Accelerated Antibodies Program
July 05, 2023
Via
ACCESSWIRE
Evotec Receives Milestone Payment for First Patient Dosed in Phase I Study of Bayer Kidney Disease Programme
June 29, 2023
Via
ACCESSWIRE
Evotec SE Annual General Meeting 2023 Approves All Proposed Agenda Items
June 20, 2023
Via
ACCESSWIRE
Evotec Presents Sustainability Strategy
June 05, 2023
Via
ACCESSWIRE
Evotec Receives Grant from Open Philanthropy for Discovery of RNA-Targeting Henipavirus Therapeutics
June 02, 2023
Via
ACCESSWIRE
Just - Evotec Biologics Enters Strategic Biosimilars Partnership with Sandoz
May 09, 2023
Via
ACCESSWIRE
Just - Evotec Biologics Launches Tech Partnership for Biosimilars Development and Commercial Manufacturing
May 09, 2023
Via
ACCESSWIRE
Cyber Attack on Evotec
April 07, 2023
Via
ACCESSWIRE
Evotec and Bristol Myers Squibb Extend and Expand Strategic Neurodegeneration Partnership
March 28, 2023
Via
ACCESSWIRE
Evotec SE Preliminary Fiscal Year 2022 Results: 'Ahead of the Curve' - Very Strong Performance in a Challenging Year
March 28, 2023
Via
ACCESSWIRE
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today